Internal Medicine, Endocrinology, Diabetes, & Metabolism · The Villages, FL
NPI
1164529293
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
7
Medicare group memberships
Hospitals
1
Hospital affiliations
1580 Santa Barbara Blvd
The Villages, FL, 32159
Phone (352) 259-2159
Groups this clinician bills Medicare through
Medicare paid, 2024
$118K
1,791 services
Medicare patients, 2024
514
Average age 74
Drug cost, 2024
$2.1M
5,182 prescriptions
Company payments, 2023
$1,375
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Madhusudhan R Banda was code 99214 (office e&m - established), 709 times for 381 patients. In total Madhusudhan R Banda billed 1,791 services in 25 codes, and Medicare paid $118K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-11-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 709 | 381 | $93.09 | $66K |
| 95251 Test - Miscellaneous | Office | 332 | 185 | $26.28 | $8,723 |
| 99232 Hospital E&M - Subsequent | Facility | 319 | 56 | $61.54 | $20K |
| 99231 Hospital E&M - Subsequent | Facility | 171 | 21 | $38.32 | $6,553 |
| 99203 Office E&M - New | Office | 113 | 113 | $80.14 | $9,056 |
| G0136 Administration of a standardized, evidence-based social determinants of health risk assessment tool, 5-15 minutes | Office | 30 | 30 | $11.89 | $357 |
| 99213 Office E&M - Established | Office | 25 | 24 | $67.47 | $1,687 |
| 76536 Ultrasound - Nonspecific | Office | 23 | 21 | $75.32 | $1,732 |
| 99222 Hospital E&M - Initial | Facility | 13 | 13 | $102.41 | $1,331 |
By year: 2022 $112K for 1,609 services; 2023 $183K for 2,758 services; 2024 $118K for 1,791 services.
Medicare prescription drug claims, 2024
In 2024, the drug Madhusudhan R Banda prescribed most often to Medicare patients was Levothyroxine Sodium, with 818 prescriptions and refills. In total Madhusudhan R Banda wrote 5,182 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 818 | 2,320 | 262 | $11K |
| Metformin Hcl Generic | 655 | 1,898 | 253 | $5,298 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 243 | 556 | 87 | $52K |
| Jardiance Empagliflozin | 206 | 516 | 80 | $295K |
| Synthroid Levothyroxine Sodium | 198 | 532 | 55 | $14K |
| Ozempic Semaglutide | 152 | 292 | 48 | $256K |
| Glimepiride Generic | 134 | 380 | 46 | $1,494 |
| Januvia Sitagliptin Phosphate | 126 | 323 | 44 | $165K |
| Glipizide Generic | 105 | 309 | 38 | $836 |
| Metformin Hcl Er Metformin Hcl | 99 | 293 | 43 | $862 |
| Novolog Flexpen Insulin Aspart | 98 | 206 | 47 | $35K |
| Tradjenta Linagliptin | 88 | 219 | 25 | $108K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 88 | 255 | 50 | $13K |
| Pioglitazone Hcl Generic | 81 | 241 | 30 | $1,407 |
| Novolog Mix 70-30 Flexpen Insulin Aspart Prot/Insuln Asp | 75 | 145 | 23 | $24K |
Brand drugs: 2,856 claims; generic drugs: 1,969 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Madhusudhan R Banda $1,375 ($1,375 in general payments such as food, travel and fees) from 8 companies. The largest payer was Novo Nordisk Inc with $1,064.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.